Acquiring Company
LSL Pharma Group
Acquired Company
Juno OTC
BouchervilleTorontoManufacturingBiotechnologyHealth CarePharmaceuticalDietary SupplementsBiotechnologyHealth CareMedicalDescription
LSL Pharma Group has reported improved revenues due to the recent acquisitions of Juno OTC and Laboratoire Du-Var. Both acquisitions have been integrated into the company's operations, providing stronger market positioning. These strategic moves are expected to enhance operational synergies and revenue growth in the coming quarters.
Fundz sees it the moment LSL Pharma Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Juno OTC?
Juno OTC was acquired by LSL Pharma Group, based in Boucherville. The deal was reported on May 25, 2026. LSL Pharma Group Inc. LSL Pharma Group is privately held and operates in Manufacturing.
When did LSL Pharma Group acquire Juno OTC?
LSL Pharma Group's acquisition of Juno OTC was reported on May 25, 2026. LSL Pharma Group has reported improved revenues due to the recent acquisitions of Juno OTC and Laboratoire Du-Var. Both acquisitions have been integrated into the company's operations, providing stronger market positioning. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Juno OTC do?
Juno OTC is a wholly owned subsidiary of Juno Pharmaceuticals LP. It offers a range of OTC drugs, natural health products, and medical devices. The company holds over 40 Health Canada approved products. It is privately held, operating in Biotechnology, and is based in Toronto.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.